Savara Inc.(SVRA)
Biotechnology
Rare Disease / Orphan Drug
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | Lowrance David L Chief Financial Officer | Sale | -394,528 | -33.45%784,816 | $5.68 | $2,241,432 | View SEC filing | |
| 2025-12-19 | RAMSAY DAVID A Director | Sale | -20,000 | -0.78%2,533,642 | $6.06 | $121,220 | View SEC filing | |
| 2025-06-23 | Hawkins Richard J Director | Purchase | +48,225 | +71.72%115,466 | $2.04 | $98,572 | View SEC filing | |
| 2025-06-02 | McCracken Joseph S Director | Purchase | +10,000 | +3.99%260,837 | $2.08 | $20,825 | View SEC filing | |
| 2025-04-01 | RAMSAY DAVID A Director | Purchase | +150,000 | +6.35%2,513,642 | $2.77 | $416,250 | View SEC filing | |
| 2024-12-16 | Lowrance David L Chief Financial Officer | Sale | -25,000 | -6.16%381,005 | $3.33 | $83,278 | View SEC filing | |
| 2024-12-16 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Sale | -54,702 | -3.44%1,536,379 | $3.31 | $180,828 | View SEC filing | |
| 2024-12-16 | Hawkins Richard J Director | Sale | -8,000 | -10.63%67,241 | $3.32 | $26,569 | View SEC filing | |
| 2024-11-20 | McCracken Joseph S Director | Purchase | +20,000 | +10.48%210,837 | $2.95 | $59,072 | View SEC filing | |
| 2024-11-18 | RAMSAY DAVID A Director | Purchase | +100,000 | +4.50%2,323,642 | $2.88 | $287,600 | View SEC filing | |
| 2023-12-29 | Pauls Matthew CHIEF EXECUTIVE OFFICER | Sale | -84,000 | -6.14%1,283,674 | $4.71 | $395,900 | View SEC filing | |
| 2023-12-29 | Lowrance David L CHIEF FINANCIAL OFFICER | Sale | -10,000 | -2.84%342,355 | $4.71 | $47,131 | View SEC filing | |
| 2023-12-29 | Elam Nevan C Director | Sale | -93,843 | -80.66%22,500 | $4.71 | $442,291 | View SEC filing | |
| 2023-07-19 | Yang Rick 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-07-19 | Walker Paul Edward 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-07-19 | SANDELL SCOTT D 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-07-19 | Mathers Edward T 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-07-19 | Makhzoumi Mohamad 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-07-19 | Florence Anthony A. Jr. 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-07-19 | Chang Carmen 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-07-19 | Behbahani Ali 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-07-19 | BASKETT FOREST 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-07-19 | New Enterprise Associates 17, L.P. 10% Owner | Purchase | +333,333 | +1.38%24,471,264 | $3.00 | $999,999 | View SEC filing | |
| 2023-06-27 | Pratt Raymond Dennis Chief Medical Officer | Purchase | +6,500 | +4.23%160,000 | $2.93 | $19,045 | View SEC filing | |
| 2023-05-26 | RAMSAY DAVID A Director | Purchase | +100,000 | +4.76%2,201,142 | $2.59 | $258,529 | View SEC filing |
1-25 of 108
Page 1 of 5